Analgin — Effectively? Cheap? Safely? What is the Alternative?

A.S. Sokolov, V.V. Nikonov, A.E. Feskov

Abstract


The problem of the treatment of post-operative pain and the pain itself remains an open problem of modern medicine. Current World Health Organization (WHO) recommendations and guidelines on the management of postoperative pain clearly indicate the need for using highly effective and safe nonopiate analgesics. The modern medical world is moving away from the use of metamizole (analgin) in the practice of acute pain relief. The current concept of effective control of postoperative pain — a multimodal approach with the use of modern, effective, safe drugs, particularly intravenous form of acetaminophen (paracetamol). Acetaminophen is approved by Food and Drug Administration for use in the USA over 50 years. Today, the drug is available in many countries without a prescription. Ace­taminophen has proven its effectiveness in many clinical trials, and is included in numerous recommendations for the treatment of chronic and postoperative pain syndrome (POPS) (WHO, 2013; Ministry of Health of Ukraine, 2014; Guidelines on the Management of Postoperative Pain, 2016). The appearance of the intravenous form of acetami­nophen on the market of pharmaceutical products expanded his using and has made it possible to reconsider approaches to control POPS, to fully apply the principle of multimodal postoperative ­analgesia.


Keywords


metamizole; acetaminophen; pain; postoperative analgesia

References


Melanie R., Lorie A. Kloda, Gilles D., Manon C. Asyste­matic literature review of 10 years of research on sex/gender and experimental pain perception. Part 1: Are there really differences between women and men? // PAIN. — 2012. — 153. — 602-618.

Jasiecka A., Maślanka T., Jaroszewski J.J. Pharmaco­logical characteristics of metamizole // Polish Journal of Veterinary Sciences. — 2014. — Vol. 17, № 1. — 207-214.

Batu O.S., Erol K. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats // Inflammopharmacology. — 2007. — 15. — 260-265.

Bar-Oz B., Clementi M., Di Giantonio E., Greenberg R., Beer M., Merlob P., Arnon J., Ornoy A., Zimmerman D.M., Berkovitch M. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study // Eur. J. Obstet. Gynecol. Reprod. Biol. — 2005. — 119. — 176-179.

Hedenmalm K., Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole) // Eur. J. Clin. Pharmacol. — 2002. — 58. — 265-274.

Basak G.W., Drozd-Sokołowska J., Wiktor-Jedrze­jczak W. Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland // J. Int. Med. Res. — 2010. — 38. — 1374-1380.

Pharmaceuticals restrictions in use and availability // WHO Pharmaceuticals Letter. — 1999. — № 1–2.

Wessel J.C., Matyja M., Neugebauer M., Kiefer H., Daldrup T., Tarbah F.A., Weber H. Characterization of oxalic acid derivatives as new metabolites of metamizol (dipyrone) in incubated hen’s egg and human // Eur. J. Pharm. Sci. — 2006. — 28. — 15-25.

The International Agranulocytosis and Aplastic Anaemia Study // JAMA. — 1986. — 256. — 1749-57.

Anonymous. Dipyrone Hearing of the German Drug Authority // Lancet. — 1986. — II. — 737.

Hedenmalm K., Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole) // Eur. J. Clin. Pharmacol. — 2002. — 58. — 265-274.

Blaser L.S., Tramonti A., Egger P. et al. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports // Eur. J. Clin. Pharmacol. — 2015. — 71. — 209-217.

Decision of Drug Registration Bureau of SMCA. Minutes No. 8 Draft of the Order of SMCA, 22 September 2000.

Ушкалова Е.А. Проблемы безопасности анальгина / Е.А. Ушкалова, А.В. Астахова // Фарматека. — 2003. — № 1. — С. 74-79.

Овечкин А.М. // Медицина неотложных состояний. — 2011. — Т. 6 (37). — С. 37-41.

Roger Chou, Debra B. Gordon, Oscar A. de Leon-Casasola et al. Guidelines on the Management of Postoperative Pain // The Journal of Pain. — 2016 February. — Vol. 17, № 2. — 131-157.

McNicol E.D., Tzortzoloulou A., Cepeda M.S. et al. Single-dose intravenous paracetamolor propacetamol for prevention or treatment of postoperative pain: A systematic review and meta-analysis // Br. J. Anaesth. — 2011. —106. — 764-775.

Ong C.K., Seymour R.A., Lirk P., Merry A.F. Combi­ning paracetamol (acetaminophen) with nonsteroidal anti-inflammatory drugs: A qualitative systematic review of analgesic efficacy for acute postoperative pain // Anesth. Analg. — 2010. — 110. — 1170-1179.

U.S. Food and Drug Administration: Information for Healthcare Professionals: Using Acetaminophen and Non­steroidal Anti-inflammatory Drugs Safely 2015 // https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/SafeUseofOver-the-CounterPainRelieversandFeverReducers/ucm164977.htm




DOI: https://doi.org/10.22141/2224-0586.2.81.2017.99695

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru